Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Xu

Showing results (661-670 of 709) with videos related to

Pageof 71
Sort By:
Oncogene|June 24, 2024
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistanceMing-Jian Ma, Yin-Hao Shi, Zhi-De Liu, et al.
Environmental Microbiology Reports|December 30, 2015
Novel species and expanded distribution of ellipsoidal multicellular magnetotactic prokaryotesYi-ran Chen, Wen-yan Zhang, Ke Zhou, et al.
Pharmacological Research|August 14, 2020
Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathwayWen-Jun Wang, Long-Fei Mao, Huan-Ling Lai, et al.
Elife|February 4, 2022
Induction of osteogenesis by bone-targeted Notch activationCong Xu, Van Vuong Dinh, Kai Kruse, et al.
Science Advances|December 5, 2020
Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EMCong Xu, Yanxing Wang, Caixuan Liu, et al.
Ebiomedicine|August 27, 2024
Multiregional dynamic contrast-enhanced MRI-based integrated system for predicting pathological complete response of axillary lymph node to neoadjuvant chemotherapy in breast cancer: multicentre studyZiyin Li, Jing Gao, Heng Zhou, et al.
Cancer|January 31, 2023
A phase 1 dose-escalation study of the poly(ADP-ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumorsBo Gao, Mark Voskoboynik, Adam Cooper, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 3, 2024
Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal AdenocarcinomaYing-Qin Zhu, Yue Huang, Yin-Hao Shi, et al.
Cancer Letters|January 30, 2024
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagyZhi-De Liu, Yin-Hao Shi, Qiong-Cong Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid TumorsBabar Bashir, Judy S Wang, Gerald Falchook, et al.
Pageof 71

Showing results (661-670 of 709) with videos related to

Sort By:
Pageof 71
Oncogene|June 24, 2024
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistanceMing-Jian Ma, Yin-Hao Shi, Zhi-De Liu, et al.
Environmental Microbiology Reports|December 30, 2015
Novel species and expanded distribution of ellipsoidal multicellular magnetotactic prokaryotesYi-ran Chen, Wen-yan Zhang, Ke Zhou, et al.
Pharmacological Research|August 14, 2020
Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathwayWen-Jun Wang, Long-Fei Mao, Huan-Ling Lai, et al.
Elife|February 4, 2022
Induction of osteogenesis by bone-targeted Notch activationCong Xu, Van Vuong Dinh, Kai Kruse, et al.
Science Advances|December 5, 2020
Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EMCong Xu, Yanxing Wang, Caixuan Liu, et al.
Ebiomedicine|August 27, 2024
Multiregional dynamic contrast-enhanced MRI-based integrated system for predicting pathological complete response of axillary lymph node to neoadjuvant chemotherapy in breast cancer: multicentre studyZiyin Li, Jing Gao, Heng Zhou, et al.
Cancer|January 31, 2023
A phase 1 dose-escalation study of the poly(ADP-ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumorsBo Gao, Mark Voskoboynik, Adam Cooper, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 3, 2024
Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal AdenocarcinomaYing-Qin Zhu, Yue Huang, Yin-Hao Shi, et al.
Cancer Letters|January 30, 2024
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagyZhi-De Liu, Yin-Hao Shi, Qiong-Cong Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid TumorsBabar Bashir, Judy S Wang, Gerald Falchook, et al.
Pageof 71